Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03110471
What this trial is testing

Nurse-led Medicines' Monitoring in Care Homes: a Process Evaluation

Who this might be right for
Dementia
Swansea University 60
Not applicableStudy completedNCT01786239
What this trial is testing

Omega-3 Dietary Supplements in Schizophrenia

Who this might be right for
SchizophreniaSchizophreniform DisorderSchizoaffective Disorder+2 more
Delbert Robinson 50
Post-approval studies (Phase 4)Study completedNCT00535145
What this trial is testing

Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychotic Disorders
Ortho-McNeil Janssen Scientific Affairs, LLC 121
Post-approval studies (Phase 4)Study completedNCT00001656
What this trial is testing

Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders

Who this might be right for
Childhood SchizophreniaPsychotic DisorderSchizophrenia
National Institute of Mental Health (NIMH) 25
Early research (Phase 1)Study completedNCT02504476
What this trial is testing

Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective

Who this might be right for
Schizophrenia or Schizoaffective Disorder
Amgen 52
Large-scale testing (Phase 3)Study completedNCT00216476
What this trial is testing

Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen-Cilag International NV 753
Not applicableUnknownNCT04409626
What this trial is testing

Hyponatraemia and Mortality in Schizophrenic and Bipolar Patients: Protocol for a Bayesian Causal Inference Study

Who this might be right for
HyponatremiaSIADH
Zealand University Hospital 31,740
Testing effectiveness (Phase 2)WithdrawnNCT00425815
What this trial is testing

Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

Who this might be right for
Schizophrenia
University of California, Los Angeles
Not applicableStudy completedNCT00956189
What this trial is testing

Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome

Who this might be right for
Metabolic Syndrome X
National Taiwan University Hospital 132
Large-scale testing (Phase 3)Ended earlyNCT01760889
What this trial is testing

SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Shire 1
Not applicableStudy completedNCT00541398
What this trial is testing

Antipsychotic Polypharmacy: Prevalence, Background and Consequences

Who this might be right for
Schizophrenia
Glostrup University Hospital, Copenhagen 222
Post-approval studies (Phase 4)Study completedNCT00763438
What this trial is testing

Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 18
Not applicableStudy completedNCT00399776
What this trial is testing

Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy

Who this might be right for
Adolescent Depression
Creighton University 60
Not applicableUnknownNCT00563017
What this trial is testing

Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone

Who this might be right for
Schizophrenia, CatatonicSchizophrenia, DisorganizedSchizophrenia, Paranoid+2 more
Hospital Authority, Hong Kong 30
Not applicableStudy completedNCT07392489
What this trial is testing

Decreasing Harms and Improving Child Health

Who this might be right for
Psychotropic DrugsPsychiatric DrugsChildren+2 more
Glyn Jones-Elwyn 31
Not applicableUnknownNCT03675750
What this trial is testing

Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 120
Not applicableStudy completedNCT00836251
What this trial is testing

Effects of Antipsychotic Medications on Energy Intake and Expenditure

Who this might be right for
SchizophreniaSchizoaffective DisorderWeight Gain
Washington University School of Medicine 15
Large-scale testing (Phase 3)Study completedNCT00107939
What this trial is testing

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Who this might be right for
Bipolar Disorder
Novartis Pharmaceuticals 453
Not applicableStudy completedNCT04002700
What this trial is testing

Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group

Who this might be right for
Stroke
Janssen Research & Development, LLC 1,234,412
Not applicableStudy completedNCT00691353
What this trial is testing

Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood Stabilizers

Who this might be right for
Bipolar Disorder
AstraZeneca 540
Next Page